Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 802-812
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.802
Figure 2
Figure 2 Progression free survival. 5-year progression free survival (PFS) = 92.8%, 10-year PFS = 82.4%, and median follow-up time = 27.78 mo (1-181 mo). PFS: Progression-free survival.